Securities code: 688658 securities abbreviation: Youcare Pharmaceutical Group Co.Ltd(688658) Announcement No.: 2022-007 Youcare Pharmaceutical Group Co.Ltd(688658)
Announcement of 2021 annual performance express
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal responsibility for the authenticity, accuracy and integrity of its contents according to law. Important content tips:
The main financial data of 2021 contained in this announcement are preliminary accounting data, which have not been audited by an accounting firm. The specific data shall be subject to the 2021 annual report of Youcare Pharmaceutical Group Co.Ltd(688658) (hereinafter referred to as “the company”), which draws the attention of investors to investment risks.
1、 Main financial data and indicators in 2021
Unit: RMB 10000
Increase and decrease of the project in the same period of last year in the current reporting period (after adjustment) (before adjustment) (%)
Total operating income 496529.46 433894.90 433894.90 14.44
Operating profit 65370.94 49215.01 49215.01 32.83
Total profit 64600.79 49513.66 49513.66 30.47
56345.21 44213.66 44213.66 27.44 net profit attributable to the owner of the parent company
Attributable to the owner of the parent company
Net profit after deducting non recurring profit and loss: 52845.66 39204.71 39204.71 34.79
Basic earnings per share (yuan) 1.25 1.23 1.23 1.63
The weighted average return on net assets was 15.05 32.94, down 17.89 percentage points
At the end of the reporting period, at the beginning of the reporting period, the increase and decrease range at the beginning of the reporting period (after adjustment) (before adjustment) (%)
Total assets 575234.57 547288.87 545699.69 5.11
Owner’s equity attributable to the parent company: 394187.66 358092.43 358092.43 10.08
Share capital 45000.00 45000.00 45000.00-
8.76 7.96 7.96 10.05 net assets per share attributable to the owner of the parent company (yuan) Note: 1. The beginning amount of this report (before adjustment) is the same as the end of last year legally disclosed.
2. The Ministry of Finance issued the accounting standards for Business Enterprises No. 21 – leasing (CaiKuai 2018 [35]) in 2018. Since January 1, 2021, the company has carried out accounting and prepared statements in accordance with the requirements of the new leasing standards, and adjusted the financial statements at the beginning of the year for the first time.
3. The above data and indicators are consolidated statement data, but have not been audited. The final results are subject to the 2021 annual report.
4. If there is a tail difference in the above increase or decrease range data, it is caused by rounding.
2、 Description of operating performance and financial status
(I) operating conditions, financial conditions and main factors affecting operating performance during the reporting period
During the reporting period, the company’s operating performance continued to grow rapidly and its profitability continued to improve.
In 2021, the company’s operating revenue and net profit attributable to the owner of the parent company after deducting non recurring profits and losses increased rapidly, realizing a total operating revenue of 4965.2946 million yuan, an increase of 14.44% over the same period of the previous year; The operating profit was 653.7094 million yuan, an increase of 32.83% over the same period last year. The net profit attributable to the owners of the parent company after deducting non recurring profits and losses was 528456600 yuan, an increase of 34.79% over the same period of last year; In 2021, the company was in good financial condition. As of December 31, 2021, the total assets of the company were 5752345700 yuan, an increase of 5.11% over the beginning of the year, the owner’s equity attributable to the parent company was 3941876600 yuan, an increase of 10.08% over the beginning of the year, and the net assets per share attributable to the owner of the parent company was 8.76 yuan, an increase of 10.05% over the beginning of the year.
Main factors affecting business performance in 2021: Based on the company’s long-term development strategy, we continued to strengthen the promotion of core products, and the revenue of key core products increased rapidly, realizing the continuous growth of overall revenue; Based on the continuous optimization of the company’s product structure and the further improvement of the overall gross profit margin, the company achieved rapid profit growth.
(II) analysis of reasons for changes in main indicators
During the reporting period, the company’s operating profit, total profit and net profit attributable to the owner of the parent company excluding non recurring profits and losses increased by 32.83%, 30.47% and 34.79% respectively year-on-year. The continuous improvement of the company’s gross profit structure during the reporting period is mainly due to the continuous improvement of the company’s main products and the continuous improvement of the company’s gross profit structure.
3、 Risk tips
The main financial data of 2021 contained in this announcement are preliminary accounting data, which have not been audited by an accounting firm. The specific data shall be subject to the data disclosed in the company’s 2021 annual report. Please pay attention to investment risks.
It is hereby announced.
Youcare Pharmaceutical Group Co.Ltd(688658) board of directors February 25, 2022
